Dose Selection Incorporating PK/PD Information in Early Phase Clinical Trials.
- 👤 Speaker: Bogachka, B (QMUL)
- 📅 Date & Time: Monday 15 August 2011, 16:35 - 17:15
- 📍 Venue: Seminar Room 2, Newton Institute Gatehouse
Abstract
Early phase clinical trials generate information on pharmacokinetic parameters and on safety issues. In addition, a dose level, or a set of dose levels, needs to be selected for further examination in later phases. If patients, rather than healthy volunteers, take part in the early phase, it may be possible to observe the effects of the drug on the disease.
In the presentation we will discuss some statistical, ethical and economic aspects of designing optimum adaptive clinical trials for dose selection incorporating both pharmacokinetic and pharmacodynamic endpoints.
Series This talk is part of the Isaac Newton Institute Seminar Series series.
Included in Lists
- All CMS events
- bld31
- dh539
- Featured lists
- INI info aggregator
- Isaac Newton Institute Seminar Series
- School of Physical Sciences
- Seminar Room 2, Newton Institute Gatehouse
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Bogachka, B (QMUL)
Monday 15 August 2011, 16:35-17:15